Oral chromuim picolinate improves carbohydrates and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats

Journal of Nutrition

Volumn 132, Issue 6, 2002, Pages 1107-1114

  Cefalu, William T ^a   Wang, Zhong Q ^a   Zhang, Xian H ^a   Baldor, Linda C ^b   Russell, James C ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Chromium; Glucose; Insulin; Lipids; Rats

Indexed keywords

CHROMIUM PICOLINATE; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; GLUCOSE TRANSPORTER; INSULIN; IRON CHELATING AGENT; MUSCLE PROTEIN; PICOLINIC ACID; PICOLINIC ACID DERIVATIVE; SLC2A4 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GLUCOSE TOLERANCE TEST; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; NONHUMAN; OBESITY; RAT; SKELETAL MUSCLE; ANIMAL; AREA UNDER THE CURVE; BLOOD; DISEASE MODEL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HYPERINSULINISM; METABOLIC SYNDROME X; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; RANDOMIZATION;

ANIMALIA;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 4; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; IRON CHELATING AGENTS; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MUSCLE, SKELETAL; OBESITY; PICOLINIC ACIDS; RANDOM ALLOCATION; RATS;

EID: 0035983152     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/132.6.1107     Document Type: Article

References (68)

1. Insulin resistance: Cellular and clinical concepts
2. Nutrition recommendations and principles for people with diabetes mellitus
3. Effect of chromium picolinate on insulin sensitivity in vivo
4. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes
5. Chromium homeostasis in patients with type II (NIDDM) diabetes
6. Chromium, glucose intolerance and diabetes
7. Nutritional factors influencing the glucose/insulin system: Chromium
8. Chromium oligopeptide activates insulin receptor tyrosine kinase activity
9. A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP)
10. Insulin resistance and impaired glucose tolerance in the atherosclerosis-prone LA/N corpulent rat
11. Dyslipidemia and diabetes: Animal models
12. Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr): Evidence for deficient plasma-to-CSF transport of leptin in both the Zucker and Koletsky obese rat
13. Vasculopathy and insulin resistance in the JCR:LA-cp rat
14. Myocardial and vascular lesions in the LA/N-corpulent rat
15. Insulin resistance and vascular wall function: Lessons from animal models
16. Serum lipids and lipoproteins in the atherosclerosis prone LA/N corpulent rat
17. Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by β, β'-tetramethylhexadecanedioic acid (MEDICA 16)
18. Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: Effect of miglitol (Bay m1099)
19. Rates of glucose utilization and glucogenesis in rats in the basal state induced by halothane anaesthesia
20. Delivery and scavenging system for small animal inhalational anesthesia
21. Characterization of glucose transporter-enriched membranes from rat skeletal muscle: Assessment of endothelial cell contamination and presence of sarcoplasmic reticulum and transverse tubules
22. Characterization of Hela 5′-nucleotidase: A stable plasma membrane marker
23. Effect of age and caloric restriction on insulin receptor binding and glucose transporter levels in aging rats
24. Chromium deficiency during total parenteral nutrition
25. Chromium and parenteral nutrition
26. Chromium deficiency, glucose intolerance, and neuropthy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition
27. Urinary excretion of chromium by humans following ingestion of chromium picoinate
28. Chromium intake, absorpion and excretion of subjects consuming self-selected diets
29. Comparison of representative ranges based on U.S. patient population and literature reference intervals for urinary trace elements
30. Blood chromium determination in assessing reference values in an unexposed Mediterranean population
31. Trace element contamination in blood-collecting devices
32. Zn contamination in vacutainer tubes
33. Sampling and analysis techniques for monitoring serum for trace elements
34. Determination of serum nickel by graphite furnace atomic absorption spectromtry with Zeeman-effect background correction: Values in a normal population and a population undergoing dialysis
35. Selection and cleaning of plastic containers for storage of trace element samples
36. Ageelated decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients - Implications for the prevention of cardiovascular disease and type II diabetes mellitus
37. Serum and urine chromium concentrations in elderly diabetics
38. Concentrations of seven trace elements in different heatological matrices in patients with type 2 diabetes as compared to healthy controls
39. Chromium levels in patients with internal diseases
40. Clinical trial of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men
41. Reversal of corticosteroid-induced diabetes mellitus with supplemental chroium
42. Dietary chromium effects on tissue chromium concentrations and chromium absorption in rats
43. Potential antioxidant effects of zinc and chromium suplementation in people with type 2 diabetes mellitus
44. Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subects
45. The inter-relationship between insulin and chromium in hyperinsulinaemic euglyaemic clamps in healthy volunteers
46. Insulin resistance and fat patterning with aging: Relationship to metabolic risk factors for cardiovascular disease
47. Contribution of visceral fat mass to the insulin resistance of aging
48. A study of caloric restriction and cardiovascular aging in cynomolgus monkeys (Macaca fascicularis): A potential model for aging research
49. Dietary reference intakes: Vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc
50. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM
51. 3]+ creases plasma cholesterol and triglycerides in rats: Towards chromium-containing therapeutics
52. Effect of chromium nicotinic acid supplementation on selected cardiovascular disease risk factors
53. Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body compoition in healthy, nonobese, older men and women
54. The biochemistry of chromium
55. Lack of effect of dietary chroium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes
56. Failure of trivalent chromium to improve hyperglycemia in diabetes mellitus
57. Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics
58. Chromium supplementation in impaired glucose tolerance of elderly: Effects on blood gluose, plasma insulin, C-peptide and lipid levels
59. Glucose metabolism in glucose-intolerant older people during chroium supplementation
60. Effects of chromium III on fasting blood glucose, cholesterol and cholesterol HDL levels in diabetics
61. Assessment of chromium metabolism in maturity onset and juvenile diabetes using chromium-51 and therapeutic response of chromium administration on plasma lipids, glucose tolerance and insulin levels
62. Effect of trivalent chromium on glucose tolerance
63. The effect of chromium picolinate on insulin controlled parameters in humans
64. Clinical use of the trace element chromium (III) in the treatment of diabetes mellitus
65. Chromium suppleentation for women with gestational diabetes mellitus
66. Chromium supplementation improves insulin resistance in patients with Type 2 diabetes mellitus
67. Follow-up survey of people in China with Type 2 diabetes mellitus consuming supplemental chromium